Viome Life Sciences announced a $25 million internal Series D and the appointment of its new chief operating officer, Kal Raman.
Khosla Ventures, Marc Benioff, Bold Capital WRG Ventures and others participated in the round.
Raman joins Viome as COO after previously holding the position of senior vice president of non-media business, marketing and retail technology at Amazon and chief digital...
Viome Life Sciences, maker of at-home tests for gut and immune system health, announced it has acquired digital health-and-wellness data company Naring Health, including its subsidiaries DiscernDX and Foodome.
Viome is split into two divisions, one selling consumer products like microbiome tests that provide diet recommendations and supplements, and the other focused on identifying biomarkers...
Viome Life Sciences announced it closed a $86.5 million oversubscribed Series C funding round, bringing its total raise to $175 million.
Bold Capital and Khosla Ventures participated in the round alongside existing and new investors.
The company also announced the launch of its Gut Intelligence Test in 200 CVS locations.
WHAT IT DOES
The company offers a total body intelligence test for users...
British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus' AI-powered data library, including its de-identified patient data.
GSK says the collaboration will allow it to leverage the U.S.-based company's library to accelerate drug discovery in oncology, improve its clinical trial design,...
Viome Life Sciences announced it had raised $67 million in Series C funding led by Bold Capital Group.
The new funding, which included participation from existing investors Khosla Ventures, West River Group, Glico, Ocgrow Ventures and Physician Partners, brings the company's raise to more than $150 million.
Viome offers gut microbiome tests for consumers and provides nutrition recommendations...
Viome Life Sciences announced Wednesday it had raised $54 million in a pre-Series C convertible funding round.
Participants in the round include existing investors Khosla Ventures, West River Group, Glico, Physician Partners and Bold Capital Group alongside new investor Ocgrow Ventures.
Viome said this latest investment brings its total capitalization to $125 million.
WHAT THEY DO
Viome is split...
